- 2017 Food as Medicine Symposium, all presentationsOriginal Date: February 11-12, 2017This discounted package includes all of the individual presentations from the conference.11.5 general CEUs approved by OBNMFasting Meets Microbiome: Just How Fun Can this Get?Presenter: Satya Ambrose, ND, LAcOriginal Date: February 11, 2017Throughout the world, now and in our past, people have fasted for many reasons, religious beliefs, health, because they had no food. So what does it do to our body when we fast, or reduce time of eating or reduce certain foods. We can change illnesses, like cancer, arthritis, brain injuries, SIBO through autophagy and rebuilding. How does the flora and fauna of our microbiome change with fasting? and what happens to our gene expression? We also explore the ways we can apply fasting techniques to our clinical practice.1.5 general CEUs approved by OBNMClinical Uses of Probiotics: Where the Rubber Meets the RoadPresenter: Robert Martindale, MDOriginal Date: February 11, 2017The clinical manipulation of the microbiome by the use of pre and probiotics in the USA has seen an exponential rise in the past 5 years. Despite the recent expansion of information the wide spread support by major medical societies the use of pre and probiotics is significantly hampered by the lack large randomized prospective studies. The lack of strain-specific data sets, lack of dose response, poor understanding of clear links to mechanism, and general misinformation about pre and probiotic products has limited the therapeutic use.As the use of probiotics grows beyond general claims of overall gut health to more targeted health claims data is starting to emerge to support use in not only clinical setting but in programs supporting health lifestyles. Much of the focus in medical and surgical practice now revolves around the protection from gut barrier disruption and alterations in intestinal permeability as well as immunologic compromise.Large prospective randomized trials have now reported benefits in prevention of Ventilator Associated Pneumonia, antibiotic associated diarrhea, and Clostridium difficile diarrhea. Smaller prospective trials have shown use of probiotics to decrease total infectious complications actually shorten hospital stays. Determining a clinically effective dose (potency) for administration of a probiotic is a key but it appears that positive data is now available in pneumonia, antibiotic associated diarrhea, and a variety of other routine clinical challenges. This presentation reviews the current clinical perspective and possible use strategy for optimizing use of “probiotics” in a medical and surgical practice as well as the use to prevent acute surgical and chronic medical diseases.1.5 general CEUs approved by OBNMAutoimmunity: Explorations in ImmunometabolismPresenter: Alena Guggenheim, NDOriginal Date: February 11, 2017Autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus are common, debilitating, and expensive diseases to manage. Current treatment strategies rarely achieve full remission, and the side effects of treatment can be severe. New research is uncovering that the immune system, like any other organ system in the body, has metabolic changes during the disease process. We are now understanding that immune mediated diseases can develop a metabolic signature, and therapies that modulate energy utilization within immune cells is uncovering new and exciting therapies.1.5 general CEUs approved by OBNMThe Role of Therapeutic Diets in the Primary Care SettingPresenter: Greg Nigh, ND, LAcOriginal Date: February 11, 2017Dietary recommendations in support of overall health are a standard feature of patient management in the naturopathic clinical setting. The utilization of short-term prescribed therapeutic diets, though, allows clinicians to use dietary programs in a much more targeted manner. Therapeutic diets can contribute a great deal toward diagnostics, and can set the stage for greater long term success with any treatment program. In this talk Dr. Nigh reviews 9 specific therapeutic diets, their clinical indications and their implementation: Elimination, Low Sulfur, Low Histamine, Low FODMAPS, Low Phenol, GAPS, SIBO, Ketogenic, and Calorie Restricted.1.5 general CEUs approved by OBNMFermented Foods and Human HealthPresenter: Sandor Ellix KatzOriginal Date: February 11, 2017Fermented foods are integral elements of culinary practices in every part of the world. This presentation discusses the reasons for this, and ways in which the process of fermentation transforms foods and beverages, with a focus on nutritional transformations. Fermentation predigests foods, making nutrients more bioavailable, breaking down many toxic compounds, and generating various by-products, some of which have been found to have therapeutic applications. The greatest health benefit of fermented foods are the bacteria themselves, which are probiotic and help to restore biodiversity in the intestines, where they contribute not only to improved digestion but also immune function, mental health, and almost every aspect of our functioning and well-being.1.5 general CEUs approved by OBNMRejoining the Wild: Food, Poop, and Worms in the World of IBDPresenter: Mark Davis, NDOriginal Date: February 12, 2017The trillions of microorganisms in your gut form a beautiful and staggeringly complex ecology that we are just learning how to see. This new learning affects our understanding of how our separation from the wild has set us up for the epidemic of hyper-inflammatory conditions which we're facing. This presentation explores new and old therapeutic interventions for inflammatory bowel disease, including food, probiotics, fecal transplant, helminths, and antimicrobials; all ways to influence the forest of the gut.1.5 general CEUs approved by OBNMExploration of the Gut-Skin Axis: The Role of the Microbiome, Lipidome and NutritionPresenter: Raja Sivamani, MD, MS, CATOriginal Date: February 12, 2017The connection between the gut and the skin has been explored in traditional medical system for many centuries. Research has started to uncover some of the biochemical mechanisms for how the gut communicates with the skin. The emerging knowledge of the microbiome and the lipid profiles (known as the lipidome) of the gut and skin will be explored. The role of long chain and short chain fatty acids in the gut and their ability to communicate with the skin are discussed along with data on how that affects the skin's sebocytes. Human studies on how foods alter the gut microbiome and the lipidome are presented in the context of practically approaching treatment for chronic skin diseases such as acne, rosacea, and psoriasis. Clinical cases are discussed with review of clinical nuances and differential diagnoses along with case management examples. The growth in knowledge of food based approaches for modulation of the microbiome, lipidome, and skin diseases further opens the possibility of integrating these concepts for development of clinical treatment approaches and high-quality collaborative clinical studies.1.5 general CEUs approved by OBNMUpdates in Clinical and Community Nutrition ResearchPresenter: Kim Tippens, ND, MS, MPHOriginal Date: February 12, 2017The field of nutrition science is complicated. While research in this field is fast-growing, contradictions in the literature challenge our clinical and personal decision-making regarding dietary behaviors. This presentation will include a review of the current research in nutrition, with a focus on whole foods dietary approaches.1.0 general CEUs approved by OBNM
